SG11201702320WA - Antitumor drug comprising beta-cyclodextrin - Google Patents

Antitumor drug comprising beta-cyclodextrin

Info

Publication number
SG11201702320WA
SG11201702320WA SG11201702320WA SG11201702320WA SG11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA SG 11201702320W A SG11201702320W A SG 11201702320WA
Authority
SG
Singapore
Prior art keywords
cyclodextrin
beta
antitumor drug
antitumor
drug
Prior art date
Application number
SG11201702320WA
Inventor
Ryuji Yamaguchi
Guy Perkins
Original Assignee
Jrc G K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jrc G K filed Critical Jrc G K
Publication of SG11201702320WA publication Critical patent/SG11201702320WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
SG11201702320WA 2014-09-25 2015-09-24 Antitumor drug comprising beta-cyclodextrin SG11201702320WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462054993P 2014-09-25 2014-09-25
US201562106236P 2015-01-22 2015-01-22
PCT/JP2015/076956 WO2016047697A1 (en) 2014-09-25 2015-09-24 ANTITUMOR AGENT INCLUDING β-CYCLODEXTRIN

Publications (1)

Publication Number Publication Date
SG11201702320WA true SG11201702320WA (en) 2017-04-27

Family

ID=55581219

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201702320WA SG11201702320WA (en) 2014-09-25 2015-09-24 Antitumor drug comprising beta-cyclodextrin

Country Status (6)

Country Link
US (1) US20170296573A1 (en)
EP (1) EP3199166B1 (en)
JP (1) JP6034542B2 (en)
SG (1) SG11201702320WA (en)
TW (1) TW201617084A (en)
WO (1) WO2016047697A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200000840A1 (en) * 2016-03-20 2020-01-02 Asdera Llc Use of cyclodextrins to reduce endocytosis in malignant and neurodegenerative disorders
US20200268788A1 (en) * 2017-08-28 2020-08-27 Asdera Llc Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation
CA3076821A1 (en) 2017-09-28 2019-04-04 Asdera Llc Use of cyclodextrins in diseases and disorders involving phospholipid dysregulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9405858A (en) * 1993-03-31 1995-12-12 Univ Pennsylvania Processes to affect the growth of living tissue in composite mammals and compositions for them
JP5703426B2 (en) * 2012-12-07 2015-04-22 国立大学法人 熊本大学 Tumor cell selective anticancer agent containing hydroxyalkylated cyclodextrin

Also Published As

Publication number Publication date
WO2016047697A1 (en) 2016-03-31
JPWO2016047697A1 (en) 2017-04-27
TW201617084A (en) 2016-05-16
US20170296573A1 (en) 2017-10-19
EP3199166A4 (en) 2018-06-06
EP3199166B1 (en) 2019-09-11
EP3199166A1 (en) 2017-08-02
JP6034542B2 (en) 2016-11-30

Similar Documents

Publication Publication Date Title
ZA201704297B (en) Pyrrolobenzodiazepine-antibody conjugates
PL3119885T3 (en) Antibody-fynomer conjugates
PL3148591T3 (en) Nanoparticle drug conjugates
GB201614443D0 (en) Targeted drug conjugates
EP3246047A4 (en) Combination drug
PL3142740T3 (en) Drug delivery devices
GB201504784D0 (en) Complexes
GB201412824D0 (en) Nanoparticles
GB201504771D0 (en) Complexes
SG11201702320WA (en) Antitumor drug comprising beta-cyclodextrin
IL249585A0 (en) Nasal administration
EP3338805A4 (en) Drug complex
GB2528654B (en) Drug dispenser assembly
IL250160A0 (en) Pharmaceutical agent
GB201508480D0 (en) Cancer
EP3111944A4 (en) Antiviral drug
EP3096691C0 (en) Catheter
GB201408176D0 (en) Ligand drug conjugates
GB201419996D0 (en) Targeted drug conjugates
GB201418984D0 (en) Novel drug conjugates
AP00817S1 (en) Soother
GB201407533D0 (en) Targeted drug conjugates
GB201419994D0 (en) Small molecule drug conjugates
GB201413986D0 (en) Saline drug
GB201401818D0 (en) Targeted drug conjugates